DOCSLIB.ORG

[TEMPLATE for SHORT FORM MONOGRAPHS (Jan 1St 2004)]

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

NATURAL HEALTH PRODUCT WORKOUT SUPPLEMENTS This monograph is intended to serve as a guide to industry for the preparation of Product Licence Applications (PLAs) and labels for natural health product market authorization. It is not intended to be a comprehensive review of the medicinal ingredients. Notes Text in parentheses is additional optional information which can be included on the PLA and product label at the applicant’s discretion. The solidus (/) indicates that the terms and/or statements are synonymous. Either term or statement may be selected by the applicant. Date August 5, 2019 Proper name(s), Common name(s), Source material(s) Table 1. Proper name(s), Common name(s), Source material(s) Group 1: Proteins Source Material(s) Proper name(s) Common name(s) Proper name(s) Part(s) Acid casein Acid casein Bos taurus Milk Alfalfa protein Alfalfa protein Medicago sativa Herb top concentrate concentrate Medicago sativa protein Medicago sativa concentrate protein concentrate Calcium caseinate Calcium caseinate Bos taurus Milk Calcium sodium caseinate Calcium sodium Bos taurus Milk caseinate Casein hydrolysate Casein hydrolysate Bos taurus Milk Hydrolyzed casein Hydrolyzed casein Defatted wheat germ Defatted wheat germ Triticum aestivum Seed germ protein protein Flaxseed protein Flaxseed protein Linum usitatissimum Seed Hemp protein concentrate Hemp protein Cannabis sativa Seed concentrate Hemp protein isolate Hemp protein isolate Cannabis sativa Seed Hemp seed protein Hemp seed protein Cannabis sativa Seed Casein Micelles Micellar casein Bos taurus Milk Milk protein concentrate Milk protein concentrate Bos taurus Milk Milk protein isolate Milk protein isolate Bos taurus Milk Pea protein Pea protein Pisum sativum Seed Potato protein Potato protein Solanum tuberosum Tuber Potato tuber protein Potato tuber protein Rice protein Rice protein Oryza sativa Seed Rice protein concentrate Rice protein concentrate Oryza sativa Seed Casein, sodium salt Sodium caseinate Bos taurus Milk Wheat protein isolate Wheat protein isolate Triticum aestivum Seed germ Whey protein concentrate Whey protein Bos taurus Milk concentrate Capra hircus Whey protein hydrolysate Whey protein Bos taurus Milk hydrolysate Capra hircus Whey protein isolate Whey protein isolate Bos taurus Milk Capra hircus Group 2: Amino acids Group 2a: Essential amino acids Source Material(s) Proper name(s) Common name(s) Common name(s) (S)-alpha-Amino-1H- L-Histidine L-Histidine imidazole-4-propanoic L-Histidine hydrochloride acid L-Histidine (2S,3S)-2-Amino-3- L-Isoleucine Ethyl L-Isoleucinate methylpentanoic acid L-Isoleucine L-Isoleucine L-Isoleucine hydrochloride N-Acetyl-L-Isoleucine (S)-2-Amino-4- L-Leucine methylpentanoic acid Leucine hydrochloride L-Leucine L-Leucine L-Leucine ethyl ester L-Leucine ethyl ester hydrochloride L-Leucine methyl ester hydrochloride N-Acetylleucine N-Glycyl-L-Leucine (S)-2,6- L-Lysine L-Lysine Diaminohexanoic acid Lysine L-Lysine-L-Aspartate L-Lysine L-Lysine monohydrochloride Lysine acetate Lysine dihydrochloride (S)-2-Amino-4- L-Methionine DL-Methionine (methylthio)butanoic Methionine L-Methionine acid N-Acetyl-L-Methionine L-Methionine (S)-2-Amino-3- L-Phenylalanine DL-Phenylalanine phenylpropanoic acid L-Phenylalanine L-Phenylalanine L-Phenylalanine methyl ester N-Acetyl-L-Phenylalanine Workout Supplements Page 2 of 34 (2S,3R)-2-Amino-3- L-Threonine DL-Threonine hydroxybutyric acid L-Threonine L-Threonine (S)-alpha-Amino-1H- L-Tryptophan L-Tryptophan indole-3-propanoic acid Tryptophan L-alpha-Aminoindole- 3-propionic acid L-Tryptophan (S)-2-Amino-3- L-Valine DL-Valine methylbutanoic acid L-Valine L-Valine L-Valine ethyl ester L-Valine ethyl ester hydrochloride L-Valine hydrochloride N-Acetyl-L-Valine Group 2b: Non-essential amino acids Source Material(s) Proper name(s) Common name(s) Common name(s) (S)-2-Aminopropanoic L-Alanine Alanylglutamine acid DL-Alanine L-Alanine L-Alanine L-Alanine ethyl ester hydrochloride (S)-2-Amino-5- L-Arginine DL-Arginine [(aminoiminomethyl) L-Arginine amino] pentanoic acid L-Arginine alpha-ketoglutarate L-Arginine L-Arginine ketoisocaproic acid L-Arginine monohydrochloride (S)-2,4-Diamino-4- L-Asparagine L-Asparagine oxobutanoic acid L-Asparagine (S)-Aminobutanedioic L-Aspartic acid L-Aspartic acid acid Potassium aspartate L-Aspartic acid Potassium magnesium aspartate (R)-2-Amino-3- L-Cysteine Cysteine hydrochloride mercaptopropanoic acid Cysteine hydrochloride monohydrate L-Cysteine D-Ribose-L-Cysteine L-Cysteine N-Acetyl-L-Cysteine (S)-2- L-Glutamate Glutamic acid hydrochloride Aminopentanedioic L- Glutamic acid L-Glutamate acid Monosodium glutamate L-Glutamic acid (S)-2,5-Diamino-5- Glutamine L-Glutamine oxopentanoic acid L-Glutamine L-Glutamine ethyl ester L-Glutamine Aminoacetic acid Glycine Glycine Glycine hydrochloride Workout Supplements Page 3 of 34 N-Glycyl-L-Leucine (S)-2- L-Proline L-Proline Pyrrolidinecarboxylic acid L-Proline (S)-2-Amino-3- L-Serine L-Serine hydroxypropanoic acid L-Serine (S)-alpha-Amino-4- L-Tyrosine L-Tyrosine hydroxybenzenepropan Tyrosine L-Tyrosine ethyl ester oic acid N-Acetyl Tyrosine L-Tyrosine Group 3: Carbohydrates Source material(s) Proper name(s) Common name(s) Common name(s) Proper name(s) Part(s) D-Fructose D-Fructose N/A Malus domestica Fruit D-Fructose N/A N/A D-Galactose D-Galactose D-Galactose N/A N/A D-Glucose Dextrose D-Glucose N/A N/A D-Glucose D-Glucose Glucose monohydrate 4-O-beta-D- Lactose Lactose N/A N/A Galactopyranosyl-D- glucose Maltodextrin Maltodextrin Maltodextrin N/A N/A D-Mannose D-Mannose D-Mannose N/A N/A Solanum tuberosum Potato starch N/A Solanum Tuber Starch - Potato tuberosum Oryza sativa Rice starch N/A Oryza sativa Seed Starch - Rice Ribo-2,3,4,5- D-Ribose D-Ribose-L- N/A N/A tetrahydroxyvaleraldehyd Ribose Cysteine e, D- Ribose Alpha-D- Cane sugar N/A Acer saccharum Sap Glucopyranosyl-beta- Saccharose Beta vulgaris Root D-fructofuranoside Sucrose Borassus Sap Beta-D- Sugar flabellifer Fructofuranosyl-alpha- Malus domestica Fruit D-glucopyranoside Oryza sativa Seed Saccharum Leaf stalk officinalis Triticum aestivum Starch - Wheat N/A Triticum aestivum Seed endosperm Wheat starch Workout Supplements Page 4 of 34 Zea mays Corn Starch N/A Zea mays Seed Starch - Maize Topical starch Zea Mays (Corn) Starch Zea mays starch Zea mays Waxy maize starch N/A Zea mays Seed Group 4: Ergogenic agents Group 4a: Non-caffeinated ergogenic agents Source material(s) Proper name(s) Common name(s) Common Proper Part(s) Preparation(s) name(s) name(s) Calcium beta-hydroxy- CaHMB Calcium beta- N/A N/A Synthetic beta-methylbutyrate Calcium beta- hydroxy-beta- hydroxy-beta- methylbutyrate methylbutyrate (L-3-Carboxy-2- L-Carnitine L-Carnitine N/A N/A N/A hydroxypropyl) Levocarnitine fumarate trimethylammonium L-Carnitine hydroxide, inner salt tartrate (R)-3-carboxy-2- hydroxy-N,N,N- trimethyl-1- propanaminium hydroxide, inner salt L-Carnitine Levocarnitine N-(aminoiminomethyl)- Creatine monohydrate Creatine N/A N/A Synthetic N-methylglycine monohydrate monohydrate Eleutherococcus Ci wu jia N/A Eleutheroc Root Dried senticosus Eleuthero occus Siberian ginseng senticosus Panax ginseng Asian ginseng N/A Panax Root Dried Chinese ginseng ginseng Rootlet Hong shen Korean ginseng Korean red ginseng Oriental ginseng Panax ginseng Red ginseng Ren shen Workout Supplements Page 5 of 34 Group 4b: Caffeine Source material(s) Proper name(s) Common name(s) Common name(s) 1,3,7-Trimethylxanthine Caffeine Caffeine 3,7-Dihydro-1,3,7-trimethyl-1H- Caffeine citrate purine-2,6-dione Group 5: Vitamins and Minerals Proper name(s) Common name(s) Source material(s) As per the current NNHPD Multi-Vitamin/Mineral Supplement monograph Group 6: Complementary ingredients Source material(s) Proper name(s) Common name(s) Common Proper Part(s) Preparation(s) name(s) name(s) Malpighia glabra Acerola N/A Malpighia Fruit Dried Barbados cherry tree glabra Fresh Escobillo 3-Aminopropanoic acid Beta-Alanine Beta- N/A N/A N/A 3-Aminopropionic acid Alanine beta-Aminopropionic Beta- acid Alanine ethyl ester Piper nigrum Black pepper N/A Piper nigrum Fruit Dried Pepper - black Pepper - white White pepper (beta- Choline Choline N/A N/A N/A hydroxyethyl)trimethyla Choline mmonium bitartrate 2-Hydroxy-N,N,N- Choline Trimethylethanaminium chloride Choline Choline citrate Choline dihydrogen citrate Choline orotate Lecithin Phosphatid ylcholine Workout Supplements Page 6 of 34 (S)-N5- Citrulline Citrulline N/A N/A N/A Carbamoylornithine L-Citrulline ethyl ester L-Citrulline Citrulline N5-(Aminocarbonyl)- malate L-ornithine L- Citrulline Capsicum annuum Cayenne N/A Capsicum Fruit Dried Cayenne pepper annuum Chili pepper Paprika Red pepper All-trans-lycopene Lycopene N/A Solanum Fruit flesh N/A Lycopene lycopersicum Psi, psi-Carotene Lycopene N/A N/A Synthetic (S)-2,5- L-Ornithine L- N/A N/A N/A Diaminopentanoic acid Ornithine (S)-alpha,delta- L-ornithine Diaminovaleric acid hydrochlor ide L- Ornithine- L- Aspartate Ornicetil 2-Aminoethanesulfonic Taurine L-Arginine N/A N/A N/A acid taurinate Taurine Taurine ethyl ester References: NHPID 2019. Route of administration Oral Dosage form(s) This monograph excludes foods or food-like dosage forms as indicated in the Compendium of Monographs Guidance Document. Acceptable dosage forms for the age category listed in this monograph and specified route of administration are indicated in the Compendium of Monographs Guidance Document. Workout Supplements Page 7 of 34 Note Liquids and solutions are not permitted for products containing Creatine monohydrate, due to lack of stability of the finished product (Dash and Sawhney 2002). Use(s) or Purpose(s) Note See Ingredient Combination section below. Products containing at least one ingredient from any of Groups 1, 2a, 2b, 3, 4a or 4b, at or above the relevant minimum doses indicated in the Dose section below Workout supplement Athletic support Products containing at least one ingredient from Group 1, at or above the minimum dose indicated in the Dose section below Source of protein for the maintenance of good health (CFIA 2019).
Recommended publications
  • Free Amino Acids in Human Amniotic Fluid. a Quantitative Study by Ion-Exchange Chromatography

    Free Amino Acids in Human Amniotic Fluid. a Quantitative Study by Ion-Exchange Chromatography

    Pediat. Res. 3: 1 13-120 (1969) Amino acids fetus amniotic fluid pregnancy Free Amino Acids in Human Amniotic Fluid. A Quantitative Study by Ion-Exchange Chromatography HARVEYL. LEVY[^^] and PAULP. MONTAG Department of Neurology, Harvard Medical School; the Joseph P. Kennedy Jr. Memorial Laboratories, Massachusetts General Hospital, Boston, Massachusetts; and the Worcester Hahnemann Hospital, Worcester, Massachusetts, USA Extract Amniotic fluid was collected at inductive amniotomy or just prior to delivery following full-term uncomplicated pregnancies. Table I lists the means, ranges, and standard deviations for the concen- trations of amino acids obtained by ion-exchange chromatography of 16 specimens of amniotic fluid. Each specimen contained the following 22 amino acids: taurine, aspartic acid, threonine, serine, glutamine, proline, glutamic acid, citrulline, glycine, alanine, a-aminobutyric acid, valine, cystine, methionine, isoleucine, tyrosine, phenylalanine, ornithine, lysine, histidine, and arginine. In addition, tryptophan, which could not be detected by the ion-exchange chromatographic method employed, was found in each specimen by paper chromatography. The amino acids present in amniotic fluid were the same as those found in samples of maternal vein, umbilical artery, and umbilical vein serum (table 11). Comparisons were made in the concentrations of several amino acids among amniotic fluid, maternal serum, umbilical artery and vein serum, and perinatal urine (table 11).Taurine was present in considerably greater concentration in amniotic fluid than in maternal serum. This amino acid is also present in large quantities in umbilical artery and vein serum (table 11) and is by far the greatest single contributor to the total free amino acid pool in perinatal urine [I].
  • The Relationship Between Citrulline Accumulation and Salt Tolerance During the Vegetative Growth of Melon (Cucumis Melo L.)

    The Relationship Between Citrulline Accumulation and Salt Tolerance During the Vegetative Growth of Melon (Cucumis Melo L.)

    The relationship between citrulline accumulation and salt tolerance during the vegetative growth of melon (Cucumis melo L.) H.Y. Dasgan1, S. Kusvuran1, K. Abak1, L. Leport2, F. Larher2, A. Bouchereau2 1Department of Horticulture, Agricultural Faculty, Cukurova University, Adana, Turkey 2Université de Rennes 1, Campus de Beaulieu, Agrocampus Rennes, Rennes Cedex, France ABSTRACT Citrulline has been recently shown to behave as a novel compatible solute in the Citrullus lanatus (Cucurbitaceae) growing under desert conditions. In the present study we have investigated some aspects of the relationship which might occur in leaves of melon seedlings, also known to produce citrulline, between the capacity to accumulate this ureido amino acid and salt tolerance. With this end in view, salt-induced changes at the citrulline level have been compared in two melon genotypes exhibiting contrasted abilities to withstand the damaging effects of high salinity. Progressive salinization of the growing solution occurred at 23 days after sowing. The final 250 mmol/l external NaCl concentration was reached within 5 days and further maintained for 16 days. In response to this treatment, it was found that the citrulline amount increased in fully expanded leaves of both genotypes according to different ki- netics. The salt tolerant genotype Midyat was induced to accumulate citrulline 4 days before the salt sensitive Yuva and as a consequence the final amount of this amino acid was twice higher in the former than in the latter. Compa- red with citrulline, the free proline level was found to be relatively low and the changes induced in response to the salt treatment exhibited different trends according to the genotypes under study.
  • I ANALYSIS of L- CITRULLINE, L-ARGININE and L-GLUTAMIC

    I ANALYSIS of L- CITRULLINE, L-ARGININE and L-GLUTAMIC

    i ANALYSIS OF L- CITRULLINE, L-ARGININE AND L-GLUTAMIC ACID IN SELECTED FRUITS, VEGETABLES, SEEDS AND NUTS SOLD IN NAIROBI CITY COUNTY, KENYA PENINNAH MUENI MULWA (B.Ed. (Sc)) I56/29384/2014 A Thesis Submitted in Partial Fulfillment of the Requirements for the Award of the Degree of Master of Science (Chemistry) in the School of Pure and Applied Sciences, Kenyatta University NOVEMBER, 2019 ii DECLARATION I hereby declare that this thesis is my original work and has not been presented for award of a degree or examination at any other University Signature ……………………………….. Date ………………… PENINNAH MUENI MULWA DEPARTMENT OF CHEMISTRY SUPERVISORS We confirm that the work referred in this thesis was carried by the candidate with our approval as University supervisors Prof. Wilson Njue Signature …………………Date …………………….. Department of Chemistry Kenyatta University Dr. Margaret Mwihaki Ng’ang’a Signature ……..............Date ……………. Department of Chemistry Kenyatta University iii DEDICATION This work is dedicated to my beloved daughter, Blessing Mumo, my father Stephen Mulwa, my mother Agnes Mulwa, my sisters Tracy and Josphine for their encouragement, moral and spiritual support as i travelled through the research journey. iv ACKNOWLEDGEMENTS First, I would like to thank the Almighty God for granting me grace to carry out the research work successfully. I am indeed grateful and would like to express my sincere appreciation to my supervisors Prof. Wilson Njue and Dr. Margaret Mwihaki Ng’ang’a both of Department of Chemistry, Kenyatta University for their tireless effort and many hours of guidance throughout the course of study. I am highly indebted to technicians, John Kamathi of Jomo Kenyatta University of Agriculture and Technology (JKUAT) and Jane Mburu, Department of Chemistry, Kenyatta University (KU) for their technical support during the LC-MS analysis of the samples.
  • The Importance of Minerals in the Long Term Health of Humans Philip H

    The Importance of Minerals in the Long Term Health of Humans Philip H

    The Importance of Minerals in the Long Term Health of Humans Philip H. Merrell, PhD Technical Market Manager, Jost Chemical Co. Calcium 20 Ca 40.078 Copper 29 Cu 63.546 Iron Magnesium 26 12 Fe Mg 55.845 24.305 Manganese Zinc 25 30 Mn Zn 55.938 65.380 Table of Contents Introduction, Discussion and General Information ..................................1 Calcium ......................................................................................................3 Copper .......................................................................................................7 Iron ...........................................................................................................10 Magnesium ..............................................................................................13 Manganese ..............................................................................................16 Zinc ..........................................................................................................19 Introduction Daily intakes of several minerals are necessary for the continued basic functioning of the human body. The minerals, Calcium (Ca), Iron (Fe), Copper (Cu), Magnesium (Mg), Manganese (Mn), and Zinc (Zn) are known to be necessary for proper function and growth of the many systems in the human body and thus contribute to the overall health of the individual. There are several other trace minerals requirements. Minimum (and in some cases maximum) daily amounts for each of these minerals have been established by the Institute of
  • Clean Lean Protein Technical Bulletin

    Clean Lean Protein Technical Bulletin

    SEPT 2015 CLEAN LEAN PROTEIN TECHNICAL BULLETIN ULTRA-HIGH BIOLOGICAL VALUE GOLDEN PEA PROTEIN, ALKALINE, NO ADDED MALTODEXTRIN, LACTOSE, POLYOLS OR FODMAPS All 9 essential amino acids. High glutamine. Very low carbs and low fat. No fillers, no artificial additives, preservatives, sweeteners, flavours or colours DISCLAIMER For educational and informational use by practitioners and businesses only The information in this Technical Bulletin is intended exclusively for business- to-business use, and not for the end consumer. The Technical Bulletin has been compiled independently by ANH Consultancy Ltd (The Atrium, Curtis Road, Dorking, Surrey RH4 1XA, UK) to provide education and information specifically for qualified healthcare practitioners, retailers and sport and fitness professionals with interests in the NuZest product range or ingredients contained within it. Accordingly, NuZest can accept no responsibility for the quality or accuracy of the material contained herein. The information and any implied health claims made are not necessarily authorised by national or EU authorities for communication to the end consumer. GLUTEN FREE • DAIRY FREE • LECTIN FREE • SOY FREE • GMO FREE T 1300 575 121 W nuzest.com.au E [email protected] facebook.com/nuzest.aus NUZEST CLEAN LEAN PROTEIN CONTENTS 1 INTRODUCTION & PRODUCT JUSTIFICATION 2 PEA PROTEIN ISOLATE 3 NUTRITIONAL PROFILE 4 MANAGING THE BODY’S AMINO ACID POOL 6 SUPPORTING ATHLETES & ACTIVE LIFESTYLES 8 WHAT’S IN CLEAN LEAN PROTEIN? 10 CLEAN LEAN PROTEIN 11 REFERENCES 12 T 1300 575 121 W nuzest.com.au E [email protected] facebook.com/nuzest.aus INTRODUCTION & PRODUCT JUSTIFICATION 2 NUZEST’S CLEAN LEAN PROTEIN (CLP) IS A UNIQUE, VEGETARIAN AND VEGAN, PROTEIN CHARACTERISED BY ITS TASTE (4 NATURAL FLAVOURS AND AN UNFLAVOURED), LACK OF FILLERS OR FOOD ADDITIVES, AND VERY HIGH DIGESTIBILITY.
  • L-Citrulline

    L-Citrulline

    L‐Citrulline Pharmacy Compounding Advisory Committee Meeting November 20, 2017 Susan Johnson, PharmD, PhD Associate Director Office of Drug Evaluation IV Office of New Drugs L‐Citrulline Review Team Ben Zhang, PhD, ORISE Fellow, OPQ Ruby Mehta, MD, Medical Officer, DGIEP, OND Kathleen Donohue, MD, Medical Officer, DGIEP, OND Tamal Chakraborti, PhD, Pharmacologist, DGIEP, OND Sushanta Chakder, PhD, Supervisory Pharmacologist, DGIEP, OND Jonathan Jarow, MD, Advisor, Office of the Center Director, CDER Susan Johnson, PharmD, PhD, Associate Director, ODE IV, OND Elizabeth Hankla, PharmD, Consumer Safety Officer, OUDLC, OC www.fda.gov 2 Nomination • L‐citrulline has been nominated for inclusion on the list of bulk drug substances for use in compounding under section 503A of the Federal Food, Drug and Cosmetic Act (FD&C Act) • It is proposed for oral use in the treatment of urea cycle disorders (UCDs) www.fda.gov 3 Physical and Chemical Characterization • Non‐essential amino acid, used in the human body in the L‐form • Well characterized substance • Soluble in water • Likely to be stable under ordinary storage conditions as solid or liquid oral dosage forms www.fda.gov 4 Physical and Chemical Characterization (2) • Possible synthetic routes – L‐citrulline is mainly produced by fermentation of L‐arginine as the substrate with special microorganisms such as the L‐arginine auxotrophs arthrobacterpa rafneus and Bacillus subtilis. – L‐citrulline can also be obtained through chemical synthesis. The synthetic route is shown in the scheme below. This
  • Nutrition & Supplements Catalog

    Nutrition & Supplements Catalog

    2 019 — 2020 But wait, there’s MORE! We can’t publish all our items in one catalog—it takes SIX catalogs! Find details about the different AZURE STANDARD catalogs we offer throughout AzureStandard.com the year on page 2. Nutrition & Supplements Catalog 971-200-8350 | 971-200-8350 Nutrition & Supplements THE ITEMS IN THIS CATALOG meet a high threshold for quality. Azure requires transparency from all the companies we work with, and we only choose suppliers that produce real foods made with only natural ingredients. That means you get nutrient-rich foods that are minimally processed with no artificial additives, no preservatives, non-GMO, no MSG, no artificial colors or flavors. That doesn’t mean every item is organic. Some are made with organic ingredients but are not Certified Organic. Some go far beyond organic. They all are earth-friendly, non-GMO and meticulously chosen for their healthful qualities. Azure’s Unacceptable Ingredient List for Food Items: Artificial Colors Certified Colors Pork Products Artificial Flavors Fluoride Shellfish Products (except Artificial Nitrates/Nitrites in Genetically Modified when used as an ingredient Meat Products Organisms (GMOs) in nutritional supplements) Artificial Preservatives Monosodium Glutamate Alcohol Artificial Sweeteners (MSG) Tobacco Bleached Flour Refined Conventional Sugars A Word about “Natural” Flavorings: Azure is currently reviewing all products that include “natural flavorings” for items that are unacceptable. All new vendors are required to sign a certification letter clearly stating
  • Increased Citrulline Amino Aciduria/Urea Cycle Disorder

    Increased Citrulline Amino Aciduria/Urea Cycle Disorder

    Newborn Screening ACT Sheet Increased Citrulline Amino Aciduria/Urea Cycle Disorder Differential Diagnosis: Citrullinemia I, argininosuccinic acidemia; citrullinemia II (citrin deficiency), pyruvate carboxylase deficiency. Condition Description: The urea cycle is the enzyme cycle whereby ammonia is converted to urea. In citrullinemia and in argininosuccinic acidemia, defects in ASA synthetase and lyase, respectively, in the urea cycle result in hyperammonemia and elevated citrulline. Medical Emergency: Take the Following IMMEDIATE Actions Contact family to inform them of the newborn screening result and ascertain clinical status (poor feeding, vomiting, lethargy, tachypnea). Immediately consult with pediatric metabolic specialist. (See attached list.) Evaluate the newborn (poor feeding, vomiting, lethargy, hypotonia, tachypnea, seizures and signs of liver disease). Measure blood ammonia. If any sign is present or infant is ill, initiate emergency treatment for hyperammonemia in consultation with metabolic specialist. Transport to hospital for further treatment in consultation with metabolic specialist. Initiate timely confirmatory/diagnostic testing and management, as recommended by specialist. Initial testing: Immediate plasma ammonia, plasma quantitative amino acids. Repeat newborn screen if second screen has not been done. Provide family with basic information about hyperammonemia. Report findings to newborn screening program. Diagnostic Evaluation: Plasma ammonia to determine presence of hyperammonemia. In citrullinemia, plasma amino
  • Marketing Research on Dietary Supplements for Periodontitis in Patient Diabetes

    Marketing Research on Dietary Supplements for Periodontitis in Patient Diabetes

    Original Study MARKETING RESEARCH ON DIETARY SUPPLEMENTS FOR PERIODONTITIS IN PATIENT DIABETES Galyna Biloklytska, Svitlana Viala, Alina Koval* National Medical Academy of Postgraduate Education named after P. L. Shupyk, Kyiv, Ukraine. ABSTRACT The vast majority of periodontal diseases are inflammatory and can develop under the influence of both local causes and the combined action of common (endogenous) and local factors against the background of changes in the reactivity of the body. In the pathogenesis of the development of periodontal diseases in patients with diabetes, the main role is given to angiopathies. Since periodontitis is characterized by various vascular disorders, which are largely similar to diabetic angiopathy, it is not easy to prove the presence of the latter with periodontitis. So some authors argue this, while, others deny it. The starting point of diabetic microangiopathies is a violation of carbohydrate metabolism, as well as a violation of glycosamine metabolism, which determines the functional and structural integrity of the vascular basement membrane. Key words: producing countries, periodontitis, diabetes mellitus, dietary supplements, medicines, dentistry. Introduction the treatment and prevention of such pathology, as periodontitis in patients with diabetes. Nowadays, the problem of treatment and rehabilitation of patients with periodontitis is quite actual, as there is an The search for modern drugs and perspective combinations increase in morbidity among people of working age, of microelements for treatment, both internally and locally, increasing demands on appearance as a factor that plays an using applications on periodontal tissues in patients with important role in professional and personal success in various types of diabetes, involves marketing analysis of society.
  • Vegan Protein Blend Ve Gan Pro Tein Blend

    Vegan Protein Blend Ve Gan Pro Tein Blend

    VEGAN PROTEIN BLEND FDA cGMP Guaranteed, Distributed by: Our unique 100% plant-based MCT Foods, LLC 630 Vernon Ave. blend is a delicious, non-GMO, Glencoe, IL 60022 high-fiber functional food that 847-835-0500 fax: 847-835-1190 is free of gluten, dairy, lactose, [email protected] soy, and corn. Orders may be placed at www.mctLean.com Discussion Clinical Applications Vegan Protein Blend is MCT Lean’s proprietary blend of • Contains 20g of protein pea protein isolate and rice protein concentrate, L-glutamine, • Contains MCTs that aid in weight loss & glycine, taurine, and SGS™ broccoli seed extract. This muscle maintenance broccoli seed extract is a super-vegetable boasting the highest level of glucoraphanin - enhancing cell detoxification • Only 6 grams net carbs per serving through free radical elimination. Our blend also contains (Cocoa flavor. Vanilla has 7g) Aminogen®, a patented, natural, plant-derived enzyme system • Supports the following: clinically proven to increase protein digestion and amino Lean body composition acid absorption - boosting nitrogen retention, aiding in the Immune health synthesis of muscle mass, and promoting deep muscle recovery. Cardiovascular health Healthy blood insulin/glucose levels Pea protein isolate features a well-balanced amino acid Gastrointestinal health BLEND PROTEIN VEGAN profile, including the highest lysine, arginine, and branched- chain amino acid (BCAA) content of all commercially available plant-based protein sources. Lysine speeds up muscle recovery time, while also playing a key role in muscle building and nitrogen level preservation. Arginine increases blood flow to allow muscles to receive nutrients and oxygen faster, thus promoting fat loss, encouraging lean muscle growth and development, and improving muscle recovery.
  • Leucine and Citrulline in Human Muscle Protein Synthesis

    Leucine and Citrulline in Human Muscle Protein Synthesis

    LEUCINE AND CITRULLINE IN HUMAN MUSCLE PROTEIN SYNTHESIS NUTRITIONAL AND CONTRACTILE REGULATION OF HUMAN MUSCLE PROTEIN SYNTHESIS: ROLE OF LEUCINE AND CITRULLINE By TYLER A. CHURCHWARD-VENNE, B.A. (HONS); M.Sc. A Thesis Submitted to the School of Graduate Studies in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy McMaster University © Copyright by Tyler A. Churchward-Venne, 2013 DOCTOR OF PHILOSOPHY (2013) McMaster University (Kinesiology) Hamilton, Ontario TITLE: Nutritional and contractile regulation of human muscle protein synthesis: role of leucine and citrulline. AUTHOR: Tyler A. Churchward-Venne, B.A. (Hons) (York University); M.Sc. (The University of Western Ontario). SUPERVISOR: Dr. Stuart M. Phillips SUPERVISORY COMMITTEE: Dr. Martin J. Gibala Dr. Gianni Parise NUMBER OF PAGES: 203 ii ABSTRACT Amino acids are key nutritional stimuli that are both substrate for muscle protein synthesis (MPS), and signaling molecules that regulate the translational machinery. There is a dose-dependent relationship between protein intake and MPS that differs between young and elderly subjects. The current thesis contains results from three separate studies that were conducted to examine to potential to enhance smaller doses of protein, known to be suboptimal in their capacity to stimulate MPS, through supplementation with specific amino acids, namely leucine and citrulline. The first two studies examined the potential to enhance the muscle protein synthetic capacity of a smaller, suboptimal dose of whey protein with leucine. In study one, we concluded that leucine supplementation of a suboptimal dose of protein could render it as effective at enhancing rates of MPS as ~four times as much protein (25 g) under resting conditions, but not following resistance exercise.
  • Arginine Is Synthesized from Proline, Not Glutamate, in Enterally Fed Human Preterm Neonates

    Arginine Is Synthesized from Proline, Not Glutamate, in Enterally Fed Human Preterm Neonates

    0031-3998/11/6901-0046 Vol. 69, No. 1, 2011 PEDIATRIC RESEARCH Printed in U.S.A. Copyright © 2010 International Pediatric Research Foundation, Inc. Arginine Is Synthesized From Proline, Not Glutamate, in Enterally Fed Human Preterm Neonates CHRIS TOMLINSON, MAHROUKH RAFII, MICHAEL SGRO, RONALD O. BALL, AND PAUL PENCHARZ Department of Paediatrics [C.T., M.S., P.P.], Research Institute [C.T., M.R., P.P.], The Hospital for Sick Children, Toronto, Ontario M5G1X8, Canada; Department of Nutritional Sciences [C.T., M.S., P.P.], University of Toronto, Toronto, Ontario M5S3E2, Canada; Department of Paediatrics [M.S.], St Michael’s Hospital, Toronto, Ontario M5B1W8, Canada; Department of Agricultural, Food and Nutritional Science [R.O.B., P.P.], University of Alberta, Edmonton, Alberta T6G2P5, Canada ABSTRACT: In neonatal mammals, arginine is synthesized in the litis (NEC) (8) and pulmonary hypertension (9). Furthermore, enterocyte, with either proline or glutamate as the dietary precursor. arginine supplementation was shown to reduce the incidence We have shown several times in piglets that proline is the only of all stages of NEC in moderately at risk infants (10) and a precursor to arginine, although in vitro evidence supports glutamate single bolus infusion of i.v. arginine improved oxygenation in in this role. Because of this uncertainty, we performed a multitracer infants with pulmonary hypertension (11). Therefore, because stable isotope study to determine whether proline, glutamate, or both are dietary precursors for arginine in enterally fed human neonates. arginine is clearly important for metabolism in the neonate, it Labeled arginine (M ϩ 2), proline (M ϩ 1), and glutamate (M ϩ 3) is critical to understand the metabolic pathways involved in its were given enterally to 15 stable, growing preterm infants (GA at synthesis.